Pathways to health with GLP-1 receptor agonism – from proteomic footprint to clinical outcomes
Ania Jastreboff; Christoffer Clemmensen; Kirsi Pietiläinen; Filip Knop
MATERIALS AVAILABLE
Coming soon
Tuesday, 13 May 2025
08:30 - 17:30
CEST
PO4.171
POSTER
A personalized treat-to-target approach for obesity management: Integrating adiposity measures with biomarker levels to reach low-risk states of incident T2D and ASCVD
Luca Busetto1; Camilla S. Morgen2; Maria Overvad2; Silvia Capucci2; Ricardo Reynoso3; Rafael Bravo2; Volker Schnecke2
MATERIALS AVAILABLE
Slide
Poster
13:30 - 15:00
CEST
Symposium
The heart of the matter: exploring person-centric approaches to obesity and cardiovascular care
Tina Vilsbøll; Pam Taub; Paolo Sbraccia; Sue D. Pedersen
MATERIALS AVAILABLE
Teaser Video
16:30 - 18:00
CEST
AD15.04
ORAL PRESENTATION
Early Clinical Benefit of Semaglutide in Adults with Overweight or Obesity and Cardiovascular Disease: A Secondary Analysis of the SELECT Trial
Jorge Plutzky1; John W. Ostrominski1; Vanita R. Aroda2; John Deanfield3; Scott S. Emerson4; G. Kees Hovingh5; Steven E. Kahn6; Sergio Leonardi7; Ildiko Lingvay8; Donna H. Ryan9; Søren Rasmussen5; Benjamin M. Scirica10; Signe Stensen5; Peter E. Weeke5; A. Michael Lincoff11
MATERIALS AVAILABLE
Slide
18:00 - 19:10
CEST
PO4.070
POSTER
Use and effectiveness of once-weekly semaglutide in US adults with overweight or obesity in clinical practice
Timothy Arnaut1; Riya Arora2; João Fernandes1
MATERIALS AVAILABLE
Poster
Wednesday, 14 May 2025
09:30 - 11:00
CEST
ORAL PRESENTATION
Impact of weight loss on MASH resolution and fibrosis improvement – What have we learned from ESSENCE
Philip N Newsome1,2; Matthew J. Armstrong3; Igor Bakulin4; Adel Belloum5; Anna MG Cali5; Anja Geerts6,7; Jacob George8; Ewa Janczewska9; Niels Krarup5; Chun-Jen Liu10,11; Håvard Midgard12; Vlad Ratziu13; Mary Rinella14; Michael Roden15,16,17; Arun J. Sanyal18; Jörn Schattenberg19; Mohamed Tawfik5; Thea Vestergaard5; Elisabetta Bugianesi20; on behalf of the ESSENCE study group